pre-IPO PHARMA

microbiotix PRESS RELEASE ARCHIVE

Jun 7, 2018

Microbiotix presents new data at the ASM Microbe 2018 Conference


Sep 14, 2017

Microbiotix and the AMR Centre Announce Co-Development Agreement Targeting Drug Resistant P. aeruginosa in Critically Ill Pneumonia Patients


May 18, 2016

Global Shigella Infections (Shigellosis) Pipeline Report 2016 - Review of Anacor Pharma, GSK, Microbiotix, Protein Potential and Visterra and Their Drug Profiles - Research and Markets


Jan 2, 2013

Microbiotix Announces Exclusive Worldwide Licensing Agreement for HCV NS5B Non-Nucleoside Polymerase Inhibitors


Google Analytics Alternative